GT Biopharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
GT Biopharma, Inc. has filed 872 SEC EDGAR filings since 12 May 1995

SEC filing history

Showing 26-50 of 59 matching filings.

Per page
25
Current page
2
10-Q File 000-08092

QUARTERLY REPORT

Filing date
14 Aug 2019
Reporting date
30 Jun 2019
Next action
Verify source filing
10-Q File 000-08092

QUARTERLY REPORT

Filing date
15 May 2019
Reporting date
31 Mar 2019
Next action
Verify source filing
10-Q File 000-08092

QUARTERLY REPORT

Filing date
14 Nov 2018
Reporting date
30 Sep 2018
Next action
Verify source filing
10-Q File 000-08092

QUARTERLY REPORT

Filing date
14 Aug 2018
Reporting date
30 Jun 2018
Next action
Verify source filing
10-Q File 000-08092

QUARTERLY REPORT

Filing date
15 May 2018
Reporting date
31 Mar 2018
Next action
Verify source filing
10-Q/A File 000-08092

FORM 10-Q/A

Filing date
28 Feb 2018
Reporting date
30 Sep 2016
Next action
Verify source filing
10-Q/A File 000-08092

FORM 10-Q/A

Filing date
28 Feb 2018
Reporting date
30 Jun 2016
Next action
Verify source filing
10-Q/A File 000-08092

FORM 10-Q/A

Filing date
28 Feb 2018
Reporting date
31 Mar 2016
Next action
Verify source filing
10-Q File 000-08092

QUARTERLY REPORT

Filing date
14 Nov 2017
Reporting date
30 Sep 2017
Next action
Verify source filing
10-Q File 000-08092

QUARTERLY REPORT

Filing date
11 Aug 2017
Reporting date
30 Jun 2017
Next action
Verify source filing
10-Q File 000-08092

QUARTERLY REPORT

Filing date
28 Apr 2017
Reporting date
31 Mar 2017
Next action
Verify source filing
10-Q File 000-08092

QUARTERLY REPORT

Filing date
14 Nov 2016
Reporting date
30 Sep 2016
Next action
Verify source filing
10-Q File 000-08092

QUARTERLY REPORT

Filing date
10 Aug 2016
Reporting date
30 Jun 2016
Next action
Verify source filing
10-Q File 000-08092

QUARTERLY REPORT

Filing date
13 May 2016
Reporting date
31 Mar 2016
Next action
Verify source filing
10-Q File 000-08092

QUARTERLY REPORT

Filing date
13 Nov 2015
Reporting date
30 Sep 2015
Next action
Verify source filing
10-Q File 000-08092

QUARTERLY REPORT

Filing date
14 Aug 2015
Reporting date
30 Jun 2015
Next action
Verify source filing
10-Q File 000-08092

QUARTERLY REPORT

Filing date
14 May 2015
Reporting date
31 Mar 2015
Next action
Verify source filing
10-Q File 000-08092

OXIS INTERNATIONAL QUARTERLY REPORT

Filing date
08 Jan 2015
Reporting date
30 Sep 2014
Next action
Verify source filing
10-Q File 000-08092

OXIS INTERNATIONAL QUARTERLY REPORT

Filing date
08 Jan 2015
Reporting date
30 Jun 2014
Next action
Verify source filing
10-Q File 000-08092

OXIS INTERNATIONAL QUARTERLY REPORT

Filing date
08 Jan 2015
Reporting date
31 Mar 2014
Next action
Verify source filing
10-Q File 000-08092

OXIS INTERNATIONAL QUARTERLY REPORT

Filing date
17 Dec 2014
Reporting date
30 Sep 2013
Next action
Verify source filing
10-Q File 000-08092

OXIS INTERNATIONAL QUARTERLY REPORT

Filing date
12 Dec 2014
Reporting date
30 Jun 2013
Next action
Verify source filing
10-Q File 000-08092

OXIS INTERNATIONAL QUARTERLY REPORT

Filing date
10 Dec 2014
Reporting date
31 Mar 2013
Next action
Verify source filing
10-Q File 000-08092

OXIS QUARTERLY REPORT

Filing date
21 Nov 2012
Reporting date
30 Sep 2012
Next action
Verify source filing
10-Q/A File 000-08092

OXIS QUARTERLY REPORT AMENDMENT NO. 1

Filing date
13 Sep 2012
Reporting date
30 Jun 2012
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .